Investors

Print
Homepage  >  MEDTOX Info  >  Investors

MEDTOX Scientific, Inc.  Investor Relations 877-715-7236

Basic Industries:  Lab & POC Diagnostic Drug Testing, Clinical Trials, Clinical Toxicology, Lead Screening, Lab Services

NASDAQ Symbol:  MTOX

NASDAQ Fundamentals

MEDTOX Focus:  Building a Business within Laboratory and Diagnostic Testing Markets

LAB DRUG TESTING                 DIAGNOSTIC TESTING                     SPECIALTY LAB TESTING
$500 Million Market*                  Multi-Billion $ Market                         $2 to $2.5 Billion Market*

* MEDTOX estimates


Vital Statistics - Year-End 2007
2007 Revenue: $80.3 Million
2007 EPS: $0.75
Shares Outstanding: 8,434,850
Approximate Public Float: 7,520,000
Insider Ownership: 11%
Institutional Ownership: 59%
Fiscal Year End: December 31

NEWS & INSIGHTS

View a recent article about synthetic drugs in the Minneapolis Star Tribune and learn about the role that MEDTOX played. 

The Department of Transportation’s Final Rule regarding the use of the Federal Drug Testing Custody and Control Form (CCF) has been published in the Federal Register.  Importantly, the Final Rule extends the deadline for use of the old CCF until November 30, 2011, and finalizes procedures for use of the new CCF. View the Federal Register document

View how MyMEDTOX clients can now locate and order drug testing at MEDTOX collection sites online.

View UPS Shipping Detail

Subscribe to the MEDTOX Journal

Workplace Drug Testing Updates

MEDTOX Ethyl Glucuronide confirmations have expanded to include Ethyl Sulfate. More Details

© 2008 MEDTOX Scientific, Inc. All rights reserved.